Affiliation:
1. Electrical and Electronics Engineering Department, Eskisehir Osmangazi University, Eskisehir 26480, Turkey
Abstract
Lung cancer is a prevalent malignancy associated with a high mortality rate, with a 5-year relative survival rate of 23%. Traditional survival analysis methods, reliant on clinician judgment, may lack accuracy due to their subjective nature. Consequently, there is growing interest in leveraging AI-based systems for survival analysis using clinical data and medical imaging. The purpose of this study is to improve survival classification for lung cancer patients by utilizing a 3D-CNN architecture (ResNet-34) applied to CT images from the NSCLC-Radiomics dataset. Through comprehensive ablation studies, we evaluate the effectiveness of different features and methodologies in classification performance. Key contributions include the introduction of a novel feature (GTV1-SliceNum), the proposal of a novel loss function (PEN-BCE) accounting for false negatives and false positives, and the showcasing of their efficacy in classification. Experimental work demonstrates results surpassing those of the existing literature, achieving a classification accuracy of 0.7434 and an ROC-AUC of 0.7768. The conclusions of this research indicate that the AI-driven approach significantly improves survival prediction for lung cancer patients, highlighting its potential for enhancing personalized treatment strategies and prognostic modeling.
Reference42 articles.
1. Cancer statistics, 2023;Siegel;CA A Cancer J. Clin.,2023
2. Zhu, X., Yao, J., and Huang, J. (2016, January 15–18). Deep convolutional neural network for survival analysis with pathological images. Proceedings of the 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Shenzhen, China.
3. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features;Yu;Nat. Commun.,2016
4. Gyorffy, B., Surowiak, P., Budczies, J., and Lanczky, A. (2013). Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer. PLoS ONE, 8.
5. Cox regression models with nonproportional hazards applied to lung cancer survival data;Ata;Hacet. J. Math. Stat.,2007